收费全文 | 11950篇 |
免费 | 693篇 |
国内免费 | 50篇 |
耳鼻咽喉 | 83篇 |
儿科学 | 482篇 |
妇产科学 | 285篇 |
基础医学 | 1782篇 |
口腔科学 | 211篇 |
临床医学 | 1320篇 |
内科学 | 2508篇 |
皮肤病学 | 240篇 |
神经病学 | 1220篇 |
特种医学 | 303篇 |
外科学 | 1133篇 |
综合类 | 76篇 |
一般理论 | 9篇 |
预防医学 | 966篇 |
眼科学 | 213篇 |
药学 | 864篇 |
中国医学 | 50篇 |
肿瘤学 | 948篇 |
2023年 | 83篇 |
2022年 | 73篇 |
2021年 | 304篇 |
2020年 | 215篇 |
2019年 | 306篇 |
2018年 | 363篇 |
2017年 | 245篇 |
2016年 | 280篇 |
2015年 | 369篇 |
2014年 | 478篇 |
2013年 | 676篇 |
2012年 | 977篇 |
2011年 | 1034篇 |
2010年 | 538篇 |
2009年 | 483篇 |
2008年 | 795篇 |
2007年 | 853篇 |
2006年 | 787篇 |
2005年 | 756篇 |
2004年 | 677篇 |
2003年 | 663篇 |
2002年 | 592篇 |
2001年 | 68篇 |
2000年 | 53篇 |
1999年 | 77篇 |
1998年 | 90篇 |
1997年 | 80篇 |
1996年 | 52篇 |
1995年 | 71篇 |
1994年 | 59篇 |
1993年 | 44篇 |
1992年 | 44篇 |
1991年 | 35篇 |
1990年 | 26篇 |
1989年 | 25篇 |
1988年 | 30篇 |
1987年 | 17篇 |
1986年 | 28篇 |
1985年 | 25篇 |
1984年 | 32篇 |
1983年 | 37篇 |
1982年 | 38篇 |
1981年 | 37篇 |
1980年 | 33篇 |
1979年 | 22篇 |
1978年 | 22篇 |
1977年 | 11篇 |
1976年 | 11篇 |
1975年 | 13篇 |
1972年 | 10篇 |
Background
Limited data exist on the clinical behavior of pediatric non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) with distant metastases at onset, and a clear standard of care has not yet been defined.Methods
This cohort study reports on pediatric adult-type metastatic NRSTS enrolled in two concurrent prospective European studies, i.e., the randomized BERNIE study and the single-arm MTS 2008 study developed by the European paediatric Soft tissue sarcoma Study Group. Treatment programs were originally designed for patients with metastatic rhabdomyosarcoma, i.e., nine courses of multidrug chemotherapy (with or without bevacizumab in the BERNIE study), followed by 12 cycles of maintenance therapy, whereas radiotherapy and/or surgery (on primary tumor and/or metastases) were delayed until after seven courses of chemotherapy had been administered.Results
The study included 61 patients <21 years old treated from July 2008 to December 2016. The lung was the site of metastases in 75% of the cases. All patients received multi-agent chemotherapy, 44% had local therapy to primary tumor, and 18% had treatment of metastases. Median time to progression/relapse was 6 months. A high rate of tumor progression was observed during the initial part of the chemotherapy program. With a median follow-up of 41.5 months (range, 2–111 months), 3-year event-free survival and overall survival were 15.4% (95% confidence interval [CI], 7.6–25.7) and 34.9% (95% CI, 22.7–47.5), respectively. There were no statistically significant differences in outcome depending on the type of treatment administered.Conclusions
The study confirmed the overall poor outcome for patients with metastatic NRSTS, whose treatment remains a challenge.Plain Language Summary
- Pediatric non-rhabdomyosarcoma soft tissue sarcomas form a heterogeneous group of rare tumors.
- Although recent international studies have defined the standard of care for patients with localized disease, limited data are available on the clinical behavior of patients with distant metastases.
- This study on 61 metastatic cases treated on two prospective European protocols confirms that the chances of survival of such patients are often dismal and a standard treatment is still lacking.
Design: Retrospective data analysis utilizing a local acute trauma registry for initial hospitalization and merged with the Dallas-Fort Worth Hospital Council registry to obtain subsequent health care utilization in the first post-injury year.
Setting: Dallas, TX, USA.
Participants: Six hundred and sixty four patients were admitted with an acute traumatic SCI from January 2003 through June 2014 to a Level I trauma center. Fifty five patients that expired during initial hospitalization and 18 patients with unspecified SCI (defined by ICD-9 with no etiology or level of injury specified) were not included in the analysis, leaving a final sample of 591.
Outcome Measures: Data included demographic and clinical characteristics, charges, and healthcare utilization.
Results: Mean age was 46.1?years (±18.9?years), the majority of patients were male (74%), and Caucasian (58%). Of the 591 patients, 345 (58%) had additional inpatient or emergency healthcare utilization accounting for 769 additional visits (median of 3 visits per person). Of the 769 encounters, 534 (69%) were inpatient and 235 (31%) were emergency visits not resulting in an admission. The most prevalent ICD-9 codes listed were pressure ulcer, neurogenic bowel, neurogenic bladder, urinary tract infection, fluid electrolyte imbalance, hypertension, and tobacco use.
Conclusion: Individuals with SCI experience high levels of healthcare utilization which are costly and may be preventable. Increasing our understanding of the prevalence and causes for healthcare utilization after acute SCI is important to target preventive strategies. 相似文献